Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Acurx Pharmaceuticals Inc have a median target of 11.57, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a 790.00% increase from the last price of 1.30.
High | 823.1% | 12.00 |
Med | 790.0% | 11.57 |
Low | 669.2% | 10.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate | +2.98% |
Average growth rate | +11.08% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼